Jodi Grodem-Maple

Stavanger, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.

Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.

Journal: NPJ Parkinson's disease
Published: February 13, 2026

Personalised prediction of institutionalisation in Parkinson's: prognostic factor identification and model development and validation using IPD meta-analysis.

Personalised prediction of institutionalisation in Parkinson's: prognostic factor identification and model development and validation using IPD meta-analysis.

Journal: Parkinsonism & related disorders
Published: February 12, 2026

Diagnostic Performance of the α-Synuclein Seed Amplification Assay for Dementia With Lewy Bodies: A Comparison Across 4 Laboratories.

Diagnostic Performance of the α-Synuclein Seed Amplification Assay for Dementia With Lewy Bodies: A Comparison Across 4 Laboratories.

Journal: Neurology
Published: January 28, 2026

Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence Cohorts.

Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence Cohorts.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 01, 2025

Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.

Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.

Journal: Clinical parkinsonism & related disorders
Published: July 21, 2025

Effects of Oral Anthocyanin Supplementation on In Vitro Neurogenesis, Hippocampus-Dependent Cognition, and Blood-Based Dementia Biomarkers: Results from a 24-Week Randomized Controlled Trial in Older Adults At Risk for Dementia (ACID).

Effects of Oral Anthocyanin Supplementation on In Vitro Neurogenesis, Hippocampus-Dependent Cognition, and Blood-Based Dementia Biomarkers: Results from a 24-Week Randomized Controlled Trial in Older Adults At Risk for Dementia (ACID).

Journal: Nutrients
Published: July 09, 2025

Dementia risk prediction in early Parkinson's disease: Validation and genetic integration of the Montreal Parkinson risk of dementia scale (MoPaRDS).

Dementia risk prediction in early Parkinson's disease: Validation and genetic integration of the Montreal Parkinson risk of dementia scale (MoPaRDS).

Journal: Journal of Parkinson's disease
Published: April 30, 2025

Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson's disease.

Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson's disease.

Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025

Circulating cell-free DNA as predictors of Parkinson's disease.

Circulating cell-free DNA as predictors of Parkinson's disease.

Journal: Parkinsonism & related disorders
Published: January 10, 2025

Cerebrospinal Fluid Phosphorylated Alpha-Synuclein in Newly Diagnosed Parkinson's Disease.

Cerebrospinal Fluid Phosphorylated Alpha-Synuclein in Newly Diagnosed Parkinson's Disease.

Journal: European journal of neurology
Published: December 30, 2024

Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's Disease.

Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 13, 2024

A systematic review of biofluid phosphorylated α-synuclein in Parkinson's disease.

A systematic review of biofluid phosphorylated α-synuclein in Parkinson's disease.

Journal: Parkinsonism & related disorders
Published: September 20, 2024
Showing 1-12 of 64

Last Updated: 09/26/2026